Mylan launches generic Frova

PITTSBURGH — Mylan on Thursday announced the launch of its generic Frova (frovatriptan succinate) tablets. The drug is indicated to treat acute migraine headaches in adults. 

 

Mylan’s tablets will be available in 2.5-mg dosage strength. The product had U.S. sales of $88.3 million for the 12 months ended March 31, according to IMS Health.